EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort

Ajda Kunčič iD, Nataša Debeljak iD, Petra Hudler iD, Janez Smerkolj iD, Mojca Urbančič iD

Acta Ophthalmologica · 2026-12 · 104 (8)

DOI: 10.1111/aos.70197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, online erschienen am 28.07.2026. Verfasst von Ajda Kunčič und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana, Slov…. Hauptthemen laut MEDLINE: Retinal Telangiectasis, Visual Acuity, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Ljubljana, Slovenian Research and Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Early diagnosis of macular telangiectasia type 2 (MacTel) remains challenging, and the contribution of genetic variation to its clinical heterogeneity is unclear. This study investigated associations between MacTel risk variants and clinical characteristics in a Slovenian cohort.

Methods

In this case–control study, including 65 patients with MacTel and 73 healthy controls, participants underwent a complete ophthalmological examination and multimodal imaging. Clinical parameters included best‐corrected visual acuity (BCVA), retinal thickness, area of ellipsoid zone (EZ) break, retinal pigment epithelium (RPE) hyperplasia and neovascularization (NV). Ten MacTel risk variants were genotyped using TaqMan assays. A polygenic risk score (PRS) was calculated, and phenotype–phenotype and genotype–phenotype associations were evaluated using correlation and regression analyses.

Results

Visual acuity declined with progressive retinal changes, including a larger area of EZ break ( ρ = 0.72), RPE hyperplasia ( ρ = 0.49) and NV ( ρ = 0.55; all p adj < 0.05). Two variants showed nominal differences in minor allele frequency between groups: rs36259 ( CERS4 ) and rs146953046 ( PHGDH ), with the latter associated with higher odds of MacTel (OR = 3.51, p = 0.040). The rs11077850‐C allele ( SNHG16 ) showed nominal associations with better BCVA (logMAR) ( ρ = −0.33, p = 0.0066), a smaller area of EZ break ( ρ = −0.27, p = 0.032) and lower odds of progressed disease (OR = 0.30, p = 0.011). These associations were attenuated after FDR correction. A PRS constructed from five MacTel risk variants, combined with age moderately discriminated patients from controls (AUC = 0.68).

Conclusion

MacTel risk variants are associated with clinically relevant functional and structural retinal changes. Integrating genetic information with multimodal imaging may support risk stratification and earlier recognition in selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal TelangiectasisVisual AcuityGenetic Predisposition to DiseasePolymorphism, Single NucleotideDNAHumansFemaleMaleSloveniaCase-Control StudiesAgedMiddle AgedTomography, Optical CoherenceFluorescein AngiographyGenetic Risk ScorePhenotypeRisk FactorsGenotypeFollow-Up StudiesFundus Oculi

Stichwörter der Autor:innen

area of ellipsoid zone breakgenotype–phenotype associationsmacular telangiectasia type 2neovascularizationpolygenic risk scoreretinal pigment epithelium hyperplasia

Substanzen

DNA

Autor:innen und Institutionen

  • Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana, Slovenia.
  • Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, University of Ljubljana, Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Ajda Kunčič, Nataša Debeljak, Petra Hudler, Janez Smerkolj, Mojca Urbančič

Förderung

  • University Medical Centre Ljubljana
  • Slovenian Research and Innovation Agency

Zitieren

APA

Kunčič, A., Debeljak, N., Hudler, P., Smerkolj, J., & Urbančič, M. (2026). Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort. Acta Ophthalmologica, 104(8). https://doi.org/10.1111/aos.70197

Vancouver

Kunčič A, Debeljak N, Hudler P, Smerkolj J, Urbančič M. Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort. Acta Ophthalmologica. 2026;104(8). doi:10.1111/aos.70197

BibTeX
@article{Kuni2026,
  author = {Kunčič, Ajda and Debeljak, Nataša and Hudler, Petra and Smerkolj, Janez and Urbančič, Mojca},
  title = {Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort},
  journal = {Acta Ophthalmologica},
  year = {2026},
  volume = {104},
  number = {8},
  doi = {10.1111/aos.70197}
}
Kostenlos starten →